Meng Yu
Fortune : 1 M $ au 30/06/2026
Fortune : 1 M $ au 30/06/2026
Meng Yu is currently the Chief Operating Officer & Executive Director at Hightide Therapeutics, Inc., a position held since 2015.
Ms. Yu completed undergraduate studies at the University of Science & Technology of China and graduate studies at the School of Medicine University of Nevada.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/04/2026 | 3 744 699 ( 0,66 % ) | 1 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| HIGHTIDE THERAPEUTICS, INC. | Directeur des opérations | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
University of Science & Technology of China
University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hightide Therapeutics, Inc.
Hightide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of therapies for the treatment of metabolic and digestive diseases | Health Technology |
School of Medicine University of Nevada
School of Medicine University of Nevada Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national